Atenafu EG - Search Results

1

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.

Waters V, Stanojevic S, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F. Waters V, et al. Among authors: atenafu eg. Eur Respir J. 2012 Jul;40(1):61-6. doi: 10.1183/09031936.00159111. Epub 2011 Dec 1. Eur Respir J. 2012. PMID: 22135280 Free article.

2

Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.

Lam W, Tjon J, Seto W, Dekker A, Wong C, Atenafu E, Bitnun A, Waters V, Yau Y, Solomon M, Ratjen F. Lam W, et al. J Antimicrob Chemother. 2007 Jun;59(6):1135-40. doi: 10.1093/jac/dkm097. Epub 2007 Apr 19. J Antimicrob Chemother. 2007. PMID: 17446242

3

Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis.

Stephenson A, Brotherwood M, Robert R, Atenafu E, Corey M, Tullis E. Stephenson A, et al. Am J Clin Nutr. 2007 May;85(5):1307-11. doi: 10.1093/ajcn/85.5.1307. Am J Clin Nutr. 2007. PMID: 17490967 Free article.

4

Longitudinal decline in lung volume in a population of children with sickle cell disease.

MacLean JE, Atenafu E, Kirby-Allen M, MacLusky IB, Stephens D, Grasemann H, Subbarao P. MacLean JE, et al. Am J Respir Crit Care Med. 2008 Nov 15;178(10):1055-9. doi: 10.1164/rccm.200708-1219OC. Epub 2008 Sep 5. Am J Respir Crit Care Med. 2008. PMID: 18776149

5

Assessment of body composition in pediatric patients with cystic fibrosis.

Wells GD, Heale L, Schneiderman JE, Wilkes DL, Atenafu E, Coates AL, Ratjen F. Wells GD, et al. Pediatr Pulmonol. 2008 Oct;43(10):1025-32. doi: 10.1002/ppul.20913. Pediatr Pulmonol. 2008. PMID: 18781652

6

Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.

Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, Tom S, Tullis E, Ratjen F. Waters V, et al. Am J Respir Crit Care Med. 2011 Mar 1;183(5):635-40. doi: 10.1164/rccm.201009-1392OC. Epub 2010 Oct 1. Am J Respir Crit Care Med. 2011. PMID: 20889901

7

Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis.

Leahy TR, Yau YC, Atenafu E, Corey M, Ratjen F, Waters V. Leahy TR, et al. Pediatr Pulmonol. 2011 May;46(5):489-96. doi: 10.1002/ppul.21383. Epub 2011 Feb 17. Pediatr Pulmonol. 2011. PMID: 21337531

8

Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.

Waters V, Atenafu EG, Salazar JG, Lu A, Yau Y, Matukas L, Tullis E, Ratjen F. Waters V, et al. Among authors: atenafu eg. J Cyst Fibros. 2012 Jan;11(1):8-13. doi: 10.1016/j.jcf.2011.07.008. Epub 2011 Aug 16. J Cyst Fibros. 2012. PMID: 21849265 Free article.

9

Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.

Waters V, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F. Waters V, et al. Among authors: atenafu eg. J Cyst Fibros. 2013 Sep;12(5):482-6. doi: 10.1016/j.jcf.2012.12.006. Epub 2013 Jan 5. J Cyst Fibros. 2013. PMID: 23294530 Free article.

10

Is asthma a vanishing disease? A study to forecast the burden of asthma in 2022.

To T, Stanojevic S, Feldman R, Moineddin R, Atenafu EG, Guan J, Gershon AS; RESPONSE Team. To T, et al. Among authors: atenafu eg. BMC Public Health. 2013 Mar 21;13:254. doi: 10.1186/1471-2458-13-254. BMC Public Health. 2013. PMID: 23517452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters